SunTrust Robinson Humphrey Downgrades ARIAD Pharmaceuticals (ARIA) to Hold
Get Alerts ARIA Hot Sheet
Price: $23.99 --0%
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
SunTrust Robinson Humphrey downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Buy to Hold with a price target of $24.00.
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $23.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Lite-On Technology Corp (2301:TT) to Underweight
- HSBC Downgrades Hannover Rueck SE (HNR1:GR) (HVRRF) to Reduce
- Goldman Sachs Downgrades Weibo Corp (9898:HK) (WB) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!